openPR Logo
Press release

Actinic Keratosis Treatment Market - Segments Worth Observing Aiding Growth Factors

03-28-2023 11:29 AM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Actinic Keratosis Treatment Market

Actinic Keratosis Treatment Market

The Actinic keratosis (AK) treatment market refers to the global market for products and therapies used to treat AK, a precancerous skin condition that can develop into squamous cell carcinoma if left untreated. The market includes both prescription and over-the-counter (OTC) products.

According to a report by Allied Market Research, the global actinic keratosis treatment market was valued at $6.26 billion in 2020 and is projected to reach $10.54 billion by 2028, growing at a CAGR of 6.5% from 2021 to 2028.

The key factors driving the growth of the market include the increasing prevalence of actinic keratosis, the growing geriatric population, and the rising awareness about the importance of early diagnosis and treatment of AK. In addition, the availability of new and advanced therapies such as photodynamic therapy, topical immunomodulators, and cryotherapy is also driving market growth.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐š๐ญ: https://www.alliedmarketresearch.com/request-sample/6354

The market is segmented by treatment type, which includes topical medications, surgical procedures, and photodynamic therapy. The topical medications segment is further sub-segmented into nonsteroidal anti-inflammatory drugs (NSAIDs), imiquimod, and 5-fluorouracil. The surgical procedures segment includes curettage and electrodessication, excisional surgery, and cryotherapy.

Geographically, North America dominates the actinic keratosis treatment market due to the high prevalence of AK in the region, increasing healthcare expenditure, and the presence of major market players. Europe is the second-largest market, while the Asia-Pacific region is expected to witness the highest growth rate during the forecast period due to the increasing awareness about AK and the growing geriatric population.

๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ, ๐ซ๐ž๐ฌ๐ญ๐ซ๐š๐ข๐ง๐ญ๐ฌ, ๐š๐ง๐ ๐จ๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ-

Increase in incidence of actinic keratosis, presence of potential drugs in pipeline, and rise in government expenditure on healthcare fuel the growth of the global actinic keratosis treatment market. On the other hand, availability of alternative treatment options impedes the growth to some extent. However, development in emerging markets is expected to create lucrative opportunities in the near future.

๐๐ซ๐จ๐œ๐ฎ๐ซ๐ž ๐‚๐จ๐ฆ๐ฉ๐ฅ๐ž๐ญ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ (๐Ÿ๐ŸŽ๐ŸŽ ๐๐š๐ ๐ž๐ฌ ๐๐ƒ๐… ๐ฐ๐ข๐ญ๐ก ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐‚๐ก๐š๐ซ๐ญ๐ฌ, ๐“๐š๐›๐ฅ๐ž๐ฌ, ๐š๐ง๐ ๐…๐ข๐ ๐ฎ๐ซ๐ž๐ฌ) @ https://www.alliedmarketresearch.com/checkout-final/e4ff2db0c8edab828b6133bada039287

๐“๐ก๐ž ๐Ÿ๐ฅ๐ฎ๐จ๐ซ๐จ๐ฎ๐ซ๐š๐œ๐ข๐ฅ ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ ๐ญ๐จ ๐ฅ๐ž๐š๐ ๐ญ๐ก๐ž ๐ญ๐ซ๐š๐ข๐ฅ ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ”

The fluorouracil segment contributed to nearly two-fifths of the global actinic keratosis treatment market share in 2018, and is expected to rule the roost by 2026. Rise in consumption of fluorouracil, ease of availability, use of fluorouracil as first line treatment, and its cost efficiency drive the growth of the segment. Simultaneously, the imiquimod segment would grow at the fastest CAGR of 5.2% during 2019-2026. Rise in patient awareness toward actinic keratosis treatment and availability of imiquimod formulation boost the growth of the segment.

๐“๐ก๐ž ๐ฉ๐ซ๐ž๐ฌ๐œ๐ซ๐ข๐ฉ๐ญ๐ข๐จ๐ง ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ ๐ก๐ž๐ฅ๐ ๐ญ๐ก๐ž ๐ฅ๐š๐ซ๐ ๐ž๐ฌ๐ญ ๐ฌ๐ก๐š๐ซ๐ž ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ–-

The prescription segment held the largest share in 2018, garnering more than four-fifths of the global actinic keratosis treatment market. The same segment would also register the fastest CAGR of 4.3% throughout the forecast period. This is due to preferable use of prescription drugs such as fluorouracil, ingenol mebutate, and imiquimod for treatment of actinic keratosis.

๐๐จ๐ซ๐ญ๐ก ๐€๐ฆ๐ž๐ซ๐ข๐œ๐š ๐ญ๐จ ๐ซ๐ฎ๐ฅ๐ž ๐ญ๐ก๐ž ๐ซ๐จ๐จ๐ฌ๐ญ ๐ข๐ง ๐ญ๐ž๐ซ๐ฆ๐ฌ ๐จ๐Ÿ ๐ซ๐ž๐ฏ๐ž๐ง๐ฎ๐ž-

North America accounted for nearly half of the global actinic keratosis treatment market revenue in 2018, and is projected to maintain the lion's share by the end of 2026. Development of actinic keratosis treatment therapeutics, increased adoption of actinic keratosis treatment drugs, and higher healthcare awareness fuel the market growth. The region across Asia-Pacific, on the other hand, would cite the fastest CAGR of 6.3% during the estimated period. This is attributed to increase in disposable income of people, growth in awareness about actinic keratosis treatment products, and rise in prevalence of the disease in southern areas, such as Australia and New Zealand.

๐…๐จ๐ซ ๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž ๐„๐ง๐ช๐ฎ๐ข๐ซ๐ฒ ๐š๐ญ: https://www.alliedmarketresearch.com/purchase-enquiry/6354

๐€๐œ๐ญ๐ข๐ง๐ข๐œ ๐Š๐ž๐ซ๐š๐ญ๐จ๐ฌ๐ข๐ฌ ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ:

Almirall, S.A.
Bausch Health Companies Inc.
Hill Dermaceuticals, Inc.
LEO Pharma A/S
Mylan N.V.
Sun Pharmaceutical Industries Ltd. (DUSA Pharmaceuticals, Inc.)
Biofrontera, Inc.
Novartis AG
Stanford Chemicals
3M Company

๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐ข๐ง ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ:

Gene Synthesis Market: https://www.alliedmarketresearch.com/gene-synthesis-market-A39015

Mobile Tomography Market: https://www.alliedmarketresearch.com/mobile-tomography-market-A31901

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Actinic Keratosis Treatment Market - Segments Worth Observing Aiding Growth Factors here

News-ID: 2991513 • Views: โ€ฆ

More Releases from Allied Market Research

Liability Insurance Market Global Opportunity Analysis and Industry Forecast, 20 โ€ฆ
Allied Market Research published a report, titled, "Liability Insurance Market by Coverage Type (General Liability Insurance, Professional Liability Insurance, Insurance for Directors and Officers), by Enterprise Size (Medium-sized Enterprises, Large Enterprises, Small Enterprises), by Application (Commercial, Personal): Global Opportunity Analysis and Industry Forecast, 2021-2031." According to the report, the global liability insurance industry generated $252.34 billion in 2021, and is expected to reach $432.81 billion by 2031, witnessing a CAGRโ€ฆ
Umbrella Insurance Market to Hit $170.7 Billion by 2031, Growing at 9.2% CAGR
Umbrella insurance is a form of casualty insurance designed to shield individuals from significant liability claims that surpass the coverage limits of their primary commercial general liability, business auto, and other business insurance policies. It offers a cost-effective solution for significantly increasing liability limits, providing added protection against catastrophic claims in today's unpredictable environment. Request Sample Pages Now: https://www.alliedmarketresearch.com/request-sample/15130 Allied Market Research published a report, titled, "Umbrella Insurance Market Size by Coverageโ€ฆ
Bancassurance Market to Reach $1.8 Trillion by 2031, Growing at 7.4% CAGR
Allied Market Research published a report, titled, "Bancassurance Market by Insurance Type (Life Insurance, Non-Life Insurance), by Model Type (Pure Distributor Model, Strategic Alliance Model, Joint Venture Model, Financial Holding, Others), by End User (Personal, Business): Global Opportunity Analysis and Industry Forecast, 2021-2031" According to the report, the global bancassurance industry generated $901.5 billion in 2021, and is estimated to reach $1.8 trillion by 2031, witnessing a CAGR of 7.4%โ€ฆ
Lendtech Market to Reach $61.9 Billion by 2031, Growing at 23.2% CAGR
Allied Market Research published a report, titled, "LendTech Market by Component (Solution and Services), Deployment Mode (On-Premises and Cloud), Type (Consumer Lending and Business Lending), Organization Size (Large Enterprises and Small and Medium-sized Enterprises), and End User (Banks, Insurance Companies, Credit Unions and NBFCs) And Region (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2022-2031" According to the report, the global lendtech industry generated $8 billionโ€ฆ

All 5 Releases


More Releases for Actinic

Actinic Keratosis Market Emerging Trends and Growth Prospects 2034
Introduction Actinic keratosis (AK), also known as solar keratosis, is one of the most common precancerous skin conditions caused by long-term ultraviolet (UV) radiation exposure. It primarily affects older adults with fair skin and is considered a precursor to squamous cell carcinoma, making early detection and treatment critical. With rising awareness of skin cancer prevention, growing dermatology consultations, and expanding therapeutic innovations, the global actinic keratosis market is experiencing significant growth. Overโ€ฆ
Actinic Keratosis Treatment Market Analysis, Size, Share & Trends | 2031
In recent years, the global Actinic Keratosis Treatment Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Actinic Keratosis Treatment Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices includingโ€ฆ
Global Actinic Keratosis Market Report Forecast to 2027
A rough, scaly area on the skin called an actinic keratosis Market develops after years of sun exposure. It commonly appears on the cheeks, lips, ears, forearms, scalp, neck, and backs of the hands. An actinic keratosis, also known as a sun keratosis, develops slowly and generally appears in persons over the age of 40. By limiting your sun exposure and protecting your skin from ultraviolet (UV) radiation, youโ€ฆ
Actinic Keratosis Market Insight, Epidemiology and Market Forecast -2026
The report studies the global Actinic Keratosis Market with many aspects of the industry like the market size, market status, market trends, and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. The report offers valuable insight into the Actinic Keratosis Market progress and approaches related to the market with an analysis of each region. The report goes on toโ€ฆ
Actinic Keratosis Treatment Market Growing Trends and Demands Analysis
The Global Actinic Keratosis Treatment Market is projected to increase at a compound annual growth rate of over 4% between 2018 and 2027. With the increased prevalence of actinic keratosis, demand for its therapeutic medications have also sprung upwards. Actinic keratosis remains an extremely common condition and its existence can be traced all over the world, however people living in countries with thinner ozone layer cover are more prone toโ€ฆ
United States Actinic Keratosis Treatment Market Report 2016
MarketResearchReports.biz has recently announced the addition of a market study โ€œ United States Actinic Keratosis Treatment Market Report 2016 โ€, is a comparative analysis of the global market. Notes: Sales, means the sales volume of Actinic Keratosis Treatment Revenue, means the sales value of Actinic Keratosis Treatment This report studies sales (consumption) of Actinic Keratosis Treatment in United States market, focuses on the top players, with sales, price, revenue and marketโ€ฆ